Clinical study on Yunnan white ointment in the treatment of fibromyalgia syndrome

首次发布于 2026 年 7 月 13 日

Shanghai Meiji Health Science and Technology Co., Ltd

计划入组 95 人 · 首次发布于 2020 年 12 月 3 日

A multicenter, randomized, double-blind, positive-controlled clinical trial to evaluate the efficacy and safety of Compound Yinhua Jiedu Granule in the treatment of influenza (wind-heat syndrome)

FM-101

Recombinant anti-EGFR chimeric antibody

KDC (Taiji Group Co. Ltd.)

Future Medicine Co., Ltd.

South Korea

GREENYN BIOTECHNOLOGY CO., LTD

Taiwan

CALGENT BIOTECHNOLOGY CO., LTD.

Taiwan

Ping An Biomedical Secures $90 Million in Strategic Investments to Accelerate Biopharmaceutical Innovation

Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease

AIM Vaccine Submits 13-Valent Pneumonia Conjugate Vaccine for Approval After Positive Phase III Results